BX three-lens brief
Evidence-based stock research on BX. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 11.9pp over 30 days. · Debt-to-equity of 66.1 — balance-sheet-heavy.
- Outperforming SPY by 11.9pp over 30 days.
- Analyst mean target $144.40 — 19% above current (20 analysts).
- Debt-to-equity of 66.1 — balance-sheet-heavy.
BX closed at $121.65 (-0.56%) as of 2026-04-25. Market cap: $148.69B. P/E (trailing) 31.2. Positives: outperforming SPY by 11.9pp over 30 days.; analyst mean target $144.40 — 19% above current (20 analysts).. Concerns: debt-to-equity of 66.1 — balance-sheet-heavy.. Last quarter: Revenue $3.43B, net income $1.76B.
Why three lenses on BX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BXacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BX brief"></iframe>